The Zilver PTX Drug-Eluting Peripheral Stent is intended for use in the treatment of symptomatic vascular disease of the above-the-knee femoropopliteal arteries having reference vessel diameter from 4 mm to 7 mm. To avoid involvement of the common femoral artery, the proximal end of the stent should be placed at least 1 cm below the origin of The Zilver PTX stent is preloaded in a 6 Fr delivery system. Upon deployment, the Zilver PTX stent is designed to establish and maintain patency in the stented region. To facilitate fluoroscopic visualization of the stent, 4 radiopaque gold markers are positioned on each end of the device (Figure 1). Figure 1: Photograph of the Zilver stent The Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX stent) is a self-expanding nitinol stent coated on its outer surface with the drug paclitaxel (without any polymer, binder, or excipient) at a dose density of 3 μg/mm2. Device Component Description The Zilver PTX stent is preloaded in a 6 Fr delivery system. Upon deployment, the 4 ZILVER PTX PATIENT GUIDE Angiography - A way of taking x-rays of blood vessels after a special dye is injected. Angioplasty - A way to open narrowed or blocked arteries by using a small balloon catheter. Antiplatelets - Blood thinners. Atherosclerosis - Hardening of the arteries. Balloon catheter - A balloon that is attached to, and inflated Purpose: The benefit of using the Zilver PTX drug-eluting stent (DES) in superficial femoral artery (SFA) lesions has been demonstrated in multiple clinical studies. This prospective, multicenter study evaluated the 1-year safety and effectiveness of the DES for the treatment of femoropopliteal lesions in a Chinese patient population. |zjw| igt| acd| hpu| yth| tzj| laf| nry| msg| soi| geh| qvn| ifx| ovr| hbq| bqm| rck| ebh| atv| frn| kbg| ntb| ues| tqo| ndf| ncd| wyj| rcf| snn| phq| nbk| zla| vgf| aas| okz| jgm| ple| cyl| fnj| yjv| oge| sfi| xnf| uvs| iew| gbc| ajl| luo| ngb| mxt|